Description: Quick-Med Technologies, Inc. is a life sciences company. The Company is focused on developing technologies for infection prevention and control in the consumer and healthcare markets. The Company offers four technologies, including NIMBUS, Stay Fresh, NimbuDerm and MultiStat. NIMBUS is a family of advanced polymers bioengineered for antimicrobial, hemostatic, and other properties that can be used in a range of medical device applications, including wound dressings, medical textiles, catheters, tubing, films and coatings. Stay Fresh is a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria even after numerous laundering cycles. NimbuDerm is a copolymer for application as a persistent hand sanitizer with long lasting protection against germs. MultiStat is a family of patented methods and compounds shown to be effective in skin therapy applications.
Home Page: www.quickmedtech.com
902 NW 4th Street
Gainesville,
FL
32601
United States
Phone:
352-379-0611
Officers
| Name | Title |
|---|---|
| Dr. Gregory S. Schultz Ph.D. | Chairman & Scientific Advisor |
| Dr. Bernd Liesenfeld | Principal Executive Officer, President & Director |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.5229 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 5 |